- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00791882
Social Skills Training in Refractory Schizophrenia (SST)
Evaluation of Social Skills Training in Reducing Negative Symptoms in Patients With Refractory Schizophrenia
Objective Primary:
To evaluate the efficacy of social skills training in reducing negative symptoms in patients with refractory schizophrenia, in comparison with control (befriending group).
Secondary:
To evaluate changes in social functioning.
To evaluate the effect of SST in other dimensions of psychopathology: positive symptoms, depression and general psychopathology.
To evaluate the impact of SST in cognition.
Hypothesis Social skills training is more effective than control group (Befriending) in reducing negative symptoms in patients with refractory schizophrenia.
Study Overview
Status
Intervention / Treatment
Detailed Description
In schizophrenia positive symptoms can be improved with an antipsychotic treatment. However there is a subgroup of patients who have a predominance of persistent negative symptoms that do not respond to antipsychotic treatment, such as blunted affect , emotional and social withdrawal, and there is evidence that such symptoms can improve with psychosocial interventions.
The objective of this study is to evaluate the efficacy of Social Skills Training on negative symptoms in patients with refractory schizophrenia by means of a randomized, single-blind controlled trial with the duration of a year, including, follow up.
This study will be conducted in two groups: one group will receive social skills training (N=46) and a control group (N=46) will attend the same number of sessions, but without intervention of the therapists (befriending).
Psychiatric, psychological and neuropsychological aspects will be evaluated at baseline, after 20 weeks and 6 months after the end of the intervention.
The scales that will be used for the psychiatric assessments are: PANSS (reduction of 20% in the negative subscale), CGI, CALGARY, SDS, and PSP, As well as the Social Skills Inventory IHS. The neuropsychological assessment will have groups of scales to measure: Attention, Memory, Executive Functions, Estimated Intellectual Efficiency and a ToM. For statistical , the repeated measure ANOVA will be used, as well as the effect size and number needed to treat.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Helio Elkis, MD PhD
- Phone Number: + 55 11 30697531
- Email: helkis@usp.br
Study Contact Backup
- Name: Silvia Scemes, BSc
- Phone Number: + 55 11 30697808
- Email: silviascemes@gmail.com
Study Locations
-
-
-
São Paulo, Brazil, 05403000
- Recruiting
- Instituto de Psiquiatria do HCFMUSP
-
Contact:
- Silvia Scemes, BSc
- Phone Number: 55 11 30697808
- Email: silviascemes@gmail.com
-
Principal Investigator:
- Helio Elkis, PhD MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of schizophrenia can´t not be over 10 years old.
- Age between 18 and 55 years old.
- A minimum of 16 in negative subscale of PANSS.
A score 4 in at least 3 of the following symptoms:
- blunted affect
- social withdrawal
- rapport
- passive social withdrawal
- lack of spontaneity
- motor retardation
- active social avoidance
- Stable disease, in use of clozapine, without recent hospitalization.
Exclusion Criteria:
- Comorbid substance use.
- Axis I comorbidity.
- History of head trauma or neurological disease.
- Clinical problems which can affect central nervous system.
- Mental retardation.
- Patients treated with other antipsychotic than clozapine.
- Patients who underwent other psychosocial treatments.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Group of behaviors by which someone express feelings, attitudes, wishes,opinions and rights , in an adequate manner regarding situation and context. Social skills are the substrate for social competence, which is the ability to find and legitimate relevant and personal goals |
A program developed during 20 weeks according to adapted BELLACK 's manual (1997),including sessions in group one hour per week.
Other Names:
|
No Intervention: 2
Control group will attend the same number of sessions, but without intervention of the therapists
|
A program developed during 20 weeks according to adapted BELLACK 's manual (1997),including sessions in group one hour per week.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Response: at least 20% decrease at PANSS - negative subscale after 20 weeks, in comparison with baseline, maintained at 26 weeks follow-up.
Time Frame: 20 weeks treatment
|
20 weeks treatment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Improvement at PSP scores
Time Frame: 20 weeks after treatment
|
20 weeks after treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Helio Elkis, MD PhD, Departamento de Psiquiatria da FMUSP
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SST
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia and Disorders With Psychotic Features
-
MaineHealthColumbia University; University of California, Irvine; Harvard UniversityCompletedPsychotic Disorders | Prodromal Schizophrenia | Severe Major Depression With Psychotic Features | Severe Bipolar Disorder With Psychotic FeaturesUnited States
-
Instituto de Investigación Hospital Universitario...CompletedSchizophrenia and Disorders With Psychotic Feature | Psychotic EpisodeSpain
-
Instituto de Investigación Hospital Universitario...Carlos III Health Institute; European Regional Development FundCompletedSchizophrenia and Disorders With Psychotic Features | Psychotic EpisodeSpain
-
University of ManchesterKing's College London; Northern Care Alliance NHS Foundation Trust; University... and other collaboratorsCompletedSchizophrenia and Disorders With Psychotic Features
-
Indiana UniversityNational Institute of Mental Health (NIMH); Yale University; University of Michigan and other collaboratorsRecruitingSchizophrenia | Schizoaffective Disorder | Major Depression With Psychotic Features | Schizophreniform Disorders | Bipolar Disorder With Psychotic FeaturesUnited States
-
The Hong Kong Polytechnic UniversityUniversity of Turku; University of Helsinki; Kowloon Hospital, Hong Kong; Pamela... and other collaboratorsCompletedCognitive Function | Schizophrenia and Disorders With Psychotic FeaturesHong Kong
-
Federal Neuro-Psychiatric Hospital, YabaUnknownSchizophrenia and Disorders With Psychotic FeaturesNigeria
-
Yale UniversityCompletedSchizophrenia and Disorders With Psychotic FeaturesUnited States
-
Centre de Recherche de l'Institut Universitaire...UnknownDisorders | Schizophrenia and Disorders With Psychotic FeaturesCanada
-
University of ArizonaInstitute for Mental Health ResearchCompletedSchizophrenia | Schizoaffective Disorder | Major Depression With Psychotic Features | Bipolar Disorder With Psychotic Features | Psychotic Disorder Not Otherwise Specified (NOS) | Recent-Onset PsychosisUnited States
Clinical Trials on Social Skills Training
-
Karolinska InstitutetThe Swedish Research Council; Region Stockholm; Stiftelsen Sunnerdahls Handikappfond and other collaboratorsCompletedDepression | Anxiety | Attention Deficit Hyperactivity Disorder (ADHD) | Autism Spectrum Disorder (ASD)Sweden
-
Karolinska InstitutetMarcus och Amalia Wallenbergs minnesfondCompletedDepression | Anxiety | Autism Spectrum Disorder | Attention Deficit Hyperactivity DisorderSweden
-
Vanderbilt UniversityUniversity of California, San DiegoCompleted
-
University of Medicine and Dentistry of New JerseyNational Institute of Mental Health (NIMH)CompletedSchizophreniaUnited States
-
Nigde Omer Halisdemir UniversityCompleted
-
Saglik Bilimleri UniversitesiCompletedBlindness | Young Adult | Blindness Congenital | Blindness and Low Vision | Visual DisorderTurkey
-
Tokyo University of Agriculture and TechnologySaitama Medical University; Ashiya UniversityUnknownDevelopmental DisabilitiesJapan
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedAutistic Disorder | AutismUnited States
-
Yale UniversityOrganization of Autism Research; Renfield FoundationCompletedPervasive Developmental DisordersUnited States
-
VA Office of Research and DevelopmentRecruitingSerious Mental IllnessUnited States